Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17014 | 622 | 36.1 | 65% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
2 | 4 | MATERIALS SCIENCE, MULTIDISCIPLINARY//PHYSICS, APPLIED//PHYSICS, CONDENSED MATTER | 2836879 |
266 | 3 | SILVER NANOPARTICLES//GOLD NANOPARTICLES//NANOPARTICLES | 44159 |
2904 | 2 | PROTEIN CORONA//BIONANO INTERACT//CARRIER ERYTHROCYTES | 2786 |
17014 | 1 | CARRIER ERYTHROCYTES//HYPOTONIC DIALYSIS//NANOERYTHROSOMES | 622 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CARRIER ERYTHROCYTES | authKW | 1192905 | 4% | 90% | 27 |
2 | HYPOTONIC DIALYSIS | authKW | 441819 | 1% | 100% | 9 |
3 | NANOERYTHROSOMES | authKW | 397635 | 1% | 90% | 9 |
4 | METHOXYPOLYETHYLENE GLYCOL | authKW | 269989 | 2% | 50% | 11 |
5 | BIOMIMETIC NANOPARTICLE | authKW | 261813 | 1% | 67% | 8 |
6 | ERYTHROSOME DERIVATIVES | authKW | 196364 | 1% | 100% | 4 |
7 | HYPOTONIC PRESWELLING | authKW | 196364 | 1% | 100% | 4 |
8 | RESEALED ERYTHROCYTES | authKW | 157089 | 1% | 80% | 4 |
9 | IFEM | address | 153406 | 1% | 63% | 5 |
10 | IMMUNOCAMOUFLAGE | authKW | 153406 | 1% | 63% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Materials Science, Biomaterials | 1288 | 8% | 0% | 48 |
2 | Pharmacology & Pharmacy | 937 | 24% | 0% | 151 |
3 | Hematology | 557 | 10% | 0% | 61 |
4 | Engineering, Biomedical | 494 | 8% | 0% | 47 |
5 | Nanoscience & Nanotechnology | 377 | 9% | 0% | 57 |
6 | Biotechnology & Applied Microbiology | 334 | 11% | 0% | 69 |
7 | Biochemistry & Molecular Biology | 245 | 20% | 0% | 126 |
8 | Medicine, Research & Experimental | 150 | 7% | 0% | 43 |
9 | Chemistry, Multidisciplinary | 140 | 13% | 0% | 78 |
10 | Biophysics | 105 | 6% | 0% | 36 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IFEM | 153406 | 1% | 63% | 5 |
2 | TRANSLAT MED THER EUTPROGRAM TARGETED TH | 98182 | 0% | 100% | 2 |
3 | PURINE S | 65453 | 0% | 67% | 2 |
4 | CANADIAN BLOOD SERV | 60101 | 3% | 8% | 16 |
5 | BIOL CHEM GIORGIO FORNAINI | 52358 | 1% | 27% | 4 |
6 | BIOCHEM G FORNAINI | 51969 | 1% | 18% | 6 |
7 | 2ND SURG CLIN | 49091 | 0% | 100% | 1 |
8 | BIOL ILITIES | 49091 | 0% | 100% | 1 |
9 | CANC RECH BIOCHEM | 49091 | 0% | 100% | 1 |
10 | CARRIER ERYTHROCYTE | 49091 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY | 33778 | 6% | 2% | 38 |
2 | ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY | 4971 | 1% | 1% | 9 |
3 | RESEARCH IN EXPERIMENTAL MEDICINE | 2567 | 1% | 1% | 7 |
4 | DRUG DELIVERY | 2408 | 1% | 1% | 8 |
5 | JOURNAL OF CONTROLLED RELEASE | 1884 | 3% | 0% | 17 |
6 | ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY | 1632 | 0% | 2% | 2 |
7 | JOURNAL OF DRUG TARGETING | 1535 | 1% | 0% | 7 |
8 | THERANOSTICS | 1332 | 1% | 1% | 4 |
9 | BIOLOGICHESKIE MEMBRANY | 1165 | 1% | 0% | 8 |
10 | ADVANCED HEALTHCARE MATERIALS | 1146 | 1% | 0% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARRIER ERYTHROCYTES | 1192905 | 4% | 90% | 27 | Search CARRIER+ERYTHROCYTES | Search CARRIER+ERYTHROCYTES |
2 | HYPOTONIC DIALYSIS | 441819 | 1% | 100% | 9 | Search HYPOTONIC+DIALYSIS | Search HYPOTONIC+DIALYSIS |
3 | NANOERYTHROSOMES | 397635 | 1% | 90% | 9 | Search NANOERYTHROSOMES | Search NANOERYTHROSOMES |
4 | METHOXYPOLYETHYLENE GLYCOL | 269989 | 2% | 50% | 11 | Search METHOXYPOLYETHYLENE+GLYCOL | Search METHOXYPOLYETHYLENE+GLYCOL |
5 | BIOMIMETIC NANOPARTICLE | 261813 | 1% | 67% | 8 | Search BIOMIMETIC+NANOPARTICLE | Search BIOMIMETIC+NANOPARTICLE |
6 | ERYTHROSOME DERIVATIVES | 196364 | 1% | 100% | 4 | Search ERYTHROSOME+DERIVATIVES | Search ERYTHROSOME+DERIVATIVES |
7 | HYPOTONIC PRESWELLING | 196364 | 1% | 100% | 4 | Search HYPOTONIC+PRESWELLING | Search HYPOTONIC+PRESWELLING |
8 | RESEALED ERYTHROCYTES | 157089 | 1% | 80% | 4 | Search RESEALED+ERYTHROCYTES | Search RESEALED+ERYTHROCYTES |
9 | IMMUNOCAMOUFLAGE | 153406 | 1% | 63% | 5 | Search IMMUNOCAMOUFLAGE | Search IMMUNOCAMOUFLAGE |
10 | CELLULAR CARRIERS | 147273 | 0% | 100% | 3 | Search CELLULAR+CARRIERS | Search CELLULAR+CARRIERS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MUZYKANTOV, VR , (2010) DRUG DELIVERY BY RED BLOOD CELLS: VASCULAR CARRIERS DESIGNED BY MOTHER NATURE.EXPERT OPINION ON DRUG DELIVERY. VOL. 7. ISSUE 4. P. 403 -427 | 132 | 49% | 103 |
2 | ZARRIN, A , FOROOZESH, M , HAMIDI, M , (2014) CARRIER ERYTHROCYTES: RECENT ADVANCES, PRESENT STATUS, CURRENT TRENDS AND FUTURE HORIZONS.EXPERT OPINION ON DRUG DELIVERY. VOL. 11. ISSUE 3. P. 433-447 | 67 | 86% | 10 |
3 | MILLAN, CG , MARINERO, MLS , CASTANEDA, AZ , LANAO, JM , (2004) DRUG, ENZYME AND PEPTIDE DELIVERY USING ERYTHROCYTES AS CARRIERS.JOURNAL OF CONTROLLED RELEASE. VOL. 95. ISSUE 1. P. 27-49 | 89 | 73% | 81 |
4 | HAMIDI, M , ZARRIN, A , FOROOZESH, M , MOHAMMADI-SAMANI, S , (2007) APPLICATIONS OF CARRIER ERYTHROCYTES IN DELIVERY OF BIOPHARMACEUTICALS.JOURNAL OF CONTROLLED RELEASE. VOL. 118. ISSUE 2. P. 145-160 | 71 | 60% | 71 |
5 | FOROOZESH, M , HAMIDI, M , ZARRIN, A , MOHAMMADI-SAMANI, S , MONTASERI, H , (2011) PREPARATION AND IN-VITRO CHARACTERIZATION OF TRAMADOL-LOADED CARRIER ERYTHROCYTES FOR LONG-TERM INTRAVENOUS DELIVERY.JOURNAL OF PHARMACY AND PHARMACOLOGY. VOL. 63. ISSUE 3. P. 322 -332 | 38 | 90% | 7 |
6 | SUN, YN , SU, J , LIU, GY , CHEN, JJ , ZHANG, XM , ZHANG, R , JIANG, MH , QIU, MF , (2017) ADVANCES OF BLOOD CELL-BASED DRUG DELIVERY SYSTEMS.EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 96. ISSUE . P. 115 -128 | 64 | 48% | 0 |
7 | MILLAN, CG , CASTANEDA, AZ , MARINERO, MLS , LANAO, JM , (2004) FACTORS ASSOCIATED WITH THE PERFORMANCE OF CARRIER ERYTHROCYTES OBTAINED BY HYPOTONIC DIALYSIS.BLOOD CELLS MOLECULES AND DISEASES. VOL. 33. ISSUE 2. P. 132-140 | 44 | 85% | 30 |
8 | BOURGEAUX, V , LANAO, JM , BAX, BE , GODFRIN, Y , (2016) DRUG-LOADED ERYTHROCYTES: ON THE ROAD TOWARD MARKETING APPROVAL.DRUG DESIGN DEVELOPMENT AND THERAPY. VOL. 10. ISSUE . P. 665 -676 | 37 | 60% | 3 |
9 | MAGNANI, M , ROSSI, L , (2014) APPROACHES TO ERYTHROCYTE-MEDIATED DRUG DELIVERY.EXPERT OPINION ON DRUG DELIVERY. VOL. 11. ISSUE 5. P. 677 -687 | 41 | 60% | 10 |
10 | BIAGIOTTI, S , PAOLETTI, MF , FRATERNALE, A , ROSSI, L , MAGNANI, M , (2011) DRUG DELIVERY BY RED BLOOD CELLS.IUBMB LIFE. VOL. 63. ISSUE 8. P. 621-631 | 37 | 61% | 22 |
Classes with closest relation at Level 1 |